CAD 0.53
(1.92%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 26.34 Million CAD | 30.75% |
2022 | 20.14 Million CAD | 112.12% |
2021 | 9.49 Million CAD | 20.13% |
2020 | 7.9 Million CAD | 234.9% |
2019 | 2.36 Million CAD | 3987.89% |
2018 | 57.75 Thousand CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 8.07 Million CAD | 66.93% |
2024 Q2 | 8.28 Million CAD | 2.65% |
2024 Q3 | 8.46 Million CAD | 2.11% |
2023 Q4 | 4.83 Million CAD | -25.47% |
2023 Q1 | 7.02 Million CAD | -11.27% |
2023 FY | 26.34 Million CAD | 30.75% |
2023 Q2 | 7.98 Million CAD | 13.62% |
2023 Q3 | 6.49 Million CAD | -18.72% |
2022 FY | 20.14 Million CAD | 112.12% |
2022 Q3 | 3.95 Million CAD | -2.9% |
2022 Q4 | 7.92 Million CAD | 100.25% |
2022 Q1 | 4.19 Million CAD | 79.28% |
2022 Q2 | 4.07 Million CAD | -2.93% |
2021 Q3 | 2.73 Million CAD | 11.07% |
2021 FY | 9.49 Million CAD | 20.13% |
2021 Q4 | 2.34 Million CAD | -14.25% |
2021 Q2 | 2.45 Million CAD | 24.77% |
2021 Q1 | 1.97 Million CAD | -12.75% |
2020 FY | 7.9 Million CAD | 234.9% |
2020 Q1 | 2.33 Million CAD | 106.65% |
2020 Q2 | 1.24 Million CAD | -46.55% |
2020 Q3 | 2.07 Million CAD | 66.21% |
2020 Q4 | 2.25 Million CAD | 9.03% |
2019 Q3 | 1.03 Million CAD | 845.87% |
2019 Q1 | 93.23 Thousand CAD | 61.43% |
2019 Q2 | 109 Thousand CAD | 16.91% |
2019 Q4 | 1.12 Million CAD | 9.41% |
2019 FY | 2.36 Million CAD | 3987.89% |
2018 Q2 | - CAD | 0.0% |
2018 Q3 | 456 Thousand CAD | 0.0% |
2018 FY | 57.75 Thousand CAD | 0.0% |
2018 Q4 | 57.75 Thousand CAD | -87.33% |
2018 Q1 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Aurora Cannabis Inc. | 270.28 Million CAD | 90.253% |
Avicanna Inc. | 16.79 Million CAD | -56.889% |
Cardiol Therapeutics Inc. | - CAD | -Infinity% |
Crescita Therapeutics Inc. | 17.52 Million CAD | -50.348% |
Knight Therapeutics Inc. | 328.19 Million CAD | 91.973% |
MediPharm Labs Corp. | 33.06 Million CAD | 20.319% |
OrganiGram Holdings Inc. | 149.2 Million CAD | 82.344% |
Canopy Growth Corporation | 297.14 Million CAD | 91.134% |
Willow Biosciences Inc. | 1.17 Million CAD | -2147.782% |
Auxly Cannabis Group Inc. | 101.07 Million CAD | 73.937% |